Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in ‘Real-World’ Setting

[GlobeNewswire] – FORWARD Clinical Study Designed to Confirm the Exceptional Results Achieved in the Evolut R CE Study DUBLIN – March 7, 2016 – Medtronic plc (NYSE: MDT) today announced the first patients enrolled in the … Read more on this. Medtronic plc (MDT) , valued at $106.31B, started the session at $75.27. Today’s price range has been between $75.23 and $75.74 per share with its 52-week range being $55.54 to $79.50. MDT shares are currently priced at 17.30x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 5.63x earnings multiple for the same period. And for those looking to make a return holding the stock, the company pays shareholders $1.52 per share annually in dividends, yielding 2.01%. In a review of the consensus earnings estimate this quarter, 22 sell-side analysts are looking at $1.27 per share, which would be $0.11 better than the year-ago quarter and a $0.00 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $4.37 is a $0.09 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $7.48 Billion. If reported, that would be a 2.47% increase over the year-ago quarter. More recently, Needham Initiated MDT at Buy (Sep 30, 2014). Previously, Barclays upgraded MDT from Equal Weight to Overweight. Investors should keep in mind is that the average price target is $84.17, which is 11.82% above where the stock opened this morning. See more in (NYSE:MDT) Similar Articles: Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic to Present Data on Micra® Transcatheter Pacing System at Upcoming FDA Advisory Committee Meeting Market Update (NYSE:MDT): Medtronic IN.PACT Admiral DEB Receives CE Mark for Treatment of AV Access In Patients with End-Stage Renal Disease Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Showcases Aortic Leadership in Innovation with Clinical Release and Pipeline at VEITH 2015